A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Open Content
Subscribe today for access to
Articles and Reports
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
White House Asks Congress to Get Moving on COVID-19 Relief Funding
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.
Non-COVID Products Help Drive QIAGEN Q1 2022 Growth
Assay tech company shares that its Q1 2022 results were better than expected in spite of declines in COVID-19 product sales.
RHCA Would Expand Medicare Coverage of Genetic Cancer Screening
Recently introduced bill would require coverage of genomic cancer testing and follow-up screening for certain at-risk individuals.
Ransomware Attacks Expose Labs to Costly Negligence Lawsuits
With cyberattacks in the health care industry on the rise, it’s more important than ever for labs to protect patient information.
Labs in Court Weekly Roundup
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
Research Shows Race May Affect Interpretation of Alzheimer’s Blood Tests
Study finds that three out of four blood tests produced different results depending on if they were used for White or Black people.
DOJ Nabs 21 Defendants for COVID-19 Fraud
The DOJ recently charged defendants in nine different US districts for allegedly carrying out COVID-19 scams worth just over $149 million.
How to Save Clinical Labs from Future Pandemic Challenges
A recent AMP report offers recommendations to policymakers to prevent problems in future public health emergencies.
MD Malpractice Premiums Rising at Rapid Rate: AMA Report
Malpractice premium costs are climbing at rates not seen since the turn of the century, according to a new AMA report.
NIPS Tests Are under Fire Again—This Time from the FDA
With increasing media coverage about problems with genetic non-invasive prenatal screening, the agency warns of risks of false results.
